Day: January 5, 2021

LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — In a release issued earlier today by GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group) under the same headline, please note the time of the conference and breakout session have changed. The conference will be held Tuesday, January 12, 2021 at 10:00 am ET (7:00 am PT). The breakout session will follow at 10:20 am ET (7:20 am PT). Complete corrected release follows: GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GW’s Chief Executive Officer, will present a business update and 2021 outlook at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:00 am ET (7:00 am...

NANTES, France, Jan. 05, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that Alexis Peyroles, Chief Executive Officer, will provide an overview of the Company’s business at the upcoming H.C. Wainwright BIOCONNECT virtual conference to be held January 11-14, 2021.The presentation will be available for on-demand listening beginning Monday, January 11, 2021, at 6:00 a.m. ET / 12:00 p.m. CET.Webcast link: https://journey.ct.events/view/39b1ab92-3f56-4949-939a-52c9a334e1e8ABOUT OSE ImmunotherapeuticsOSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. The company’s immunology research and development platform is focused on three areas: T-cell-based vaccination,...

GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive securities purchase agreement with certain institutional and accredited investors to purchase, in a registered direct offering, 550,000 shares of ProPhase common stock, at a purchase price of $10.00 per share, together with warrants to purchase 275,000 shares of ProPhase common stock at a purchase price of $11.00 per share. Subject to customary closing conditions, the transaction is expected to close on Thursday, January 7, 2021.ProPhase anticipates that the net proceeds from this offering, after deducting offering expenses, will be used for working capital and general corporate purposes. No placement agent or broker dealer was used or participated...

ProVen VCT plc5 January 2021Statement re Offer for Subscription – Additional Shares for Early ApplicationsProVen VCT plc (the “Company”) is pleased to announce that the Offer for Subscription which opened on 3 December 2020 (the “Offer”) has seen a strong level of demand and that the first £5 million in gross applications, the level at which applicants who submit valid applications under the Offer will benefit from additional shares, has been received.Applicants for whom valid application forms were, or are, received by or on behalf of the Company after the first £5 million of gross applications were received will not benefit from additional shares in the Company under the Offer.The Offer will close not later than 5.00pm on 31 March 2021 in respect of the 2020/2021 Offer and not later than 5.00pm on 30 April 2021 in respect...

Date:        Wednesday, February 3, 2021Time:        9:00 a.m. (ET)BROOKFIELD, NEWS, Jan. 05, 2021 (GLOBE NEWSWIRE) — You are invited to participate in Brookfield Infrastructure Partners’ 2020 Fourth Quarter Conference Call and Webcast on Wednesday, February 3, 2021 at 9:00 a.m. (Eastern Time) to discuss results and current business initiatives with members of senior management.These results will be released on February 3, 2020 at approximately 7:00 a.m. (Eastern Time) and will also be available following the release on our website at www.brookfield.com/infrastructure.To participate in the conference call, please dial 1-866-688-9459 toll-free in North America, or for overseas calls please dial +1-409-216-0834 at approximately 8:50 a.m. (Conference ID: 4178742). The conference call will be webcast live at https://edge.media-server.com/mmc/p/63nh6f4w...

NACON APPRISES PARTNERSTHAT THE SINKING CITY RETURNS TO STORESLesquin, 5 January 2021 – A dispute between NACON and Frogwares on the interpretation of the publishing contract for the video game “The Sinking City” is still pending before the French courts for several months. For the sake of transparency, Nacon wishes to inform its partners and customers that a first enforceable decision was rendered by the Paris Court of Appeal on October 28, 2020.The Court ruled that Frogwares had terminated the contract in a “manifestly unlawful” manner and, as a result, ordered, as a “precautionary measure, the continuation of the contract (…) until its term or until a decision is made on the breach of this contract and ordered Frogwares Ireland to refrain from any action on the breach of this contract and ordered...

NACON INFORME SES PARTENAIRESDU RETOUR DE THE SINKING CITY SUR LES STORESLesquin, le 5 janvier 2021 – Un différend opposant NACON à FROGWARES sur l’interprétation du contrat d’édition du jeu vidéo The Sinking City est pendant devant les juridictions françaises depuis plusieurs mois. Dans un souci de transparence, NACON entend informer ses partenaires et ses clients qu’une première décision exécutoire a été rendue par la Cour d’appel de Paris le 28 octobre 2020.La Cour a jugé que Frogwares avait résilié le contrat de manière « manifestement illicite » et, en conséquence, ordonne à titre « conservatoire, la poursuite du contrat (…) jusqu’à son terme ou jusqu’à ce qu’une décision intervienne sur la rupture de ce contrat et ordonne à la société Frogwares Ireland de s’abstenir de tout agissement sur la rupture de ce contrat et ordonne...

Information relative au nombre total de droits de vote et d’actions composant le capital social établie conformément aux dispositions de l’article L. 233-8 II du code de commerce et de l’article 223-16 du Règlement général de l’AMFLa Motte-Fanjas, le 5 janvier 2021 – 17h45 CET – McPhy (Euronext Paris Compartiment C : MCPHY, FR0011742329) spécialiste des équipements de production et distribution d’hydrogène, annonce aujourd’hui la déclaration du nombre total des droits de vote et du nombre d’actions au 31 décembre 2020. Société déclarante Dénomination sociale : McPhy Energy S.A. Siège social : 1115 route de Saint-Thomas – 26190 La Motte-Fanjas Immatriculée sous le n° 502 205 917 R.C.S. Romans Euronext Paris Compartiment C (Code ISIN : FR0011742329 – MCPHY) Nombre d’actions formant le capital de la Société Nombre de droits de voteA...

Paris, 5th January 2021 – 17:45COFACE SA: Half-year statement of the liquidity agreement of COFACE SA with ODDO BHFPursuant to Regulation (EU) No 596/2014 of 16 April 2014 on market abuse1As per the liquidity contract granted by COFACE SA to ODDO BHF on COFACE SA shares (Code ISIN FR0010667147), the following assets appeared on the liquidity account as at 31 December 2020:168,239 COFACE SA shares1,550,624.80 EurosAs a reminder, on the date of signature of the contract, the following resources appeared in the dedicated liquidity account:76,542 COFACE SA shares2,171,235.7 EurosDuring the period from 30/06/2020 to 31/12/2020 were executed:Buy transactions: 2,816Sell transactions: 2,819During the same period, the traded volumes represented:Buy transactions: 1,297,006 shares for 9,140,834.8 EurosSell transactions: 1,400,089 shares for 9,959,773.3...